124 related articles for article (PubMed ID: 8515299)
21. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
Moody JA; Gerding DN; Peterson LR
Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
[TBL] [Abstract][Full Text] [Related]
22. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy.
Schito GC; Sanna A; Chezzi C; Ravizzola G; Leone F; Molinari G; Menozzi MG; Pirali F
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():57-72. PubMed ID: 2681128
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria.
Louie A; Baltch AL; Ritz WJ; Smith RP
Chemotherapy; 1991; 37(4):275-82. PubMed ID: 1665123
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of cefpirome against microorganisms isolated in haematology, oncology and intensive care units in Switzerland.
Liassine N; Bille J; Breer C; Frei R; Wüst J; Auckenthaler R
Scand J Infect Dis; 1997; 29(6):615-21. PubMed ID: 9571744
[TBL] [Abstract][Full Text] [Related]
25. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076
[TBL] [Abstract][Full Text] [Related]
26. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
[TBL] [Abstract][Full Text] [Related]
27. Overview of Scandinavian in vitro studies with ciprofloxacin.
Forsgren A
Scand J Infect Dis Suppl; 1989; 60():16-22. PubMed ID: 2667106
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534.
Jones RN; Sanchez ML
Diagn Microbiol Infect Dis; 1994 Jan; 18(1):61-8. PubMed ID: 8026159
[TBL] [Abstract][Full Text] [Related]
29. In-vitro susceptibility of clinical isolates of Serratia species to antimicrobial agents.
Sofianou D; Proya E; Kondodimou A
J Chemother; 1990 Apr; 2(2):79-81. PubMed ID: 2362189
[TBL] [Abstract][Full Text] [Related]
30. Bactericidal activity of cefpirome (HR 810) against 513 gram-negative bacteria isolated from blood of septicemic patients.
Bergeron MG; Bernier M
Infection; 1994; 22(4):299-305. PubMed ID: 8002094
[TBL] [Abstract][Full Text] [Related]
31. Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
Piccolomini R; Ravagnan G
Chemioterapia; 1986 Aug; 5(4):249-56. PubMed ID: 3769047
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of trovafloxacin (CP 99,219), a new fluoroquinolone against hospital isolates.
Ling TK; Liu EY; Cheng AF
Chemotherapy; 1999; 45(1):22-7. PubMed ID: 9876206
[TBL] [Abstract][Full Text] [Related]
33. The comparative in-vitro activity of pefloxacin.
King A; Phillips I
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
[TBL] [Abstract][Full Text] [Related]
34. Antibacterial activity of trovafloxacin against nosocomial Gram-positive and Gram-negative isolates.
Cunha BA; Qadri SM; Ueno Y; Walters EA; Domenico P
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():29-34. PubMed ID: 9222067
[TBL] [Abstract][Full Text] [Related]
35. Temocillin. In vitro antibacterial activity.
Slocombe B; Cooper CE; Griffin KE; White AR
Drugs; 1985; 29 Suppl 5():49-56. PubMed ID: 3849425
[TBL] [Abstract][Full Text] [Related]
36. Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.
Machka K; Braveny I
Eur J Clin Microbiol; 1987 Aug; 6(4):482-5. PubMed ID: 3117538
[TBL] [Abstract][Full Text] [Related]
37. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
Lei YC; Wang HB; Sun ZY; Shen ZY
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
[TBL] [Abstract][Full Text] [Related]
39. The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Neu HC; Chin NX; Gu JW
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():83-94. PubMed ID: 1328138
[TBL] [Abstract][Full Text] [Related]
40. In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.
Sofianou DC; Douboyas JP
J Chemother; 1991 Feb; 3(1):3-5. PubMed ID: 1902252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
